Sanokrizin in tbc
In 57 patients with tbc III stage, the author used sanokrizin in doses from 0.01 to 1.0 in 4-5 days, depending on the reaction. In 11 cases there was a significant improvement, in 24 cases improvement, 11 patients remained unchanged, and in 12 patients deterioration was observed (in 3-4 cases, in direct dependence on sanokrizin application).
Oyfebach M.
/
| 〈 |
|
〉 |
PDF
